N@N

Market Maker Surveillance Report. MVIS, MDGN, ENMD, FBMI, APAGF, CMXI, Winning Stocks With Lowest Price Friction For Thursday,

July 5, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4525 companies with "abnormal" market making, 2680 companies with positive Friction Factors and 2688 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Microvision Inc (NASDAQ:MVIS), MEDGENICS INC - UNRESTRICTED (OTCBB:MDGN), Entremed Inc (NASDAQ:ENMD), FIRSTBANK CORP/ALMA MICH (NASDAQ:FBMI), APCO OIL AND GAS INTL INC (NASDAQ:APAGF), CYTOMEDIX INC (OTC:CMXI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  MVIS    $0.450    28.30%    1,080,757    53.68%    932,116      46.30%    148,641      3,303   
  MDGN    $4.510    43.01%    176,162      37.04%    143,066      30.08%    33,096       73      
  ENMD    $0.480    24.00%    92,562       62.72%    53,327       36.13%    39,235       817     
  FBMI    $1.840    19.07%    41,869       60.45%    27,388       39.55%    14,481       79      
  APAGF   $2.920    14.94%    64,003       57.05%    47,488       42.33%    16,515       57      
  CMXI    $0.230    19.49%    119,107      38.02%    100,646      32.12%    18,461       803     

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows MVIS with a dollar gain Thursday of $0.45000 and a Friction Factor of 3,303 shares. That means that it only took 3,303 more shares of buying than selling to move MVIS higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

Microvision Inc (NASDAQ:MVIS) - MicroVision, Inc. engages in the development of miniature laser display and imaging engines based upon its proprietary PicoP display engine technology. Its technology uses two dimensional micro-electrical mechanical systems, lasers, optics, and electronics to create a video or still image from a small form factor device. The companys products include Pico projector displays for portable hand-held devices, including mobile phones, as well as to function as an accessory device that connects to mobile video sources, such as tablet PCs, smartphones, personal media players, or laptop computers. Its products also comprise automotive head-up displays that project high-resolution images onto the windshield of an automobile providing the driver with information comprising GPS mapping images, audio controls, and other automobile instrumentation related to the car's operation. In addition, the company offers near-eye wearable display platform to provide personal viewing of information from a mobile device through a wired or wireless connection. Further, it provides ROV hand held bar code scanners and bar code scanner enabled enterprise solutions to end users through distributors and its online store. MicroVision, Inc. serves the customers in the consumer, defense, industrial, and medical markets. The company was founded in 1993 and is headquartered in Redmond, Washington.

MEDGENICS INC - UNRESTRICTED (OTCBB:MDGN) - Medgenics, Inc., a biopharmaceutical company, through its subsidiary Medgenics Medical Israel Ltd., engages in the research and development of products in the field of biotechnology and associated medical equipment. Its Biopump platform technology allows patients to produce their natural human protein therapy for the treatment of a range of chronic diseases, such as anemia and hepatitis C. The company develops EPODURE, a Phase I/II clinical trial product for the treatment of chronic renal anemia; and INFRADURE for the treatment of hepatitis C. It also develops a pipeline of products based on its Biopump technology, such as clotting Factor VIII for the treatment of hemophilia. The companys platform technology also has the potential to treat a range of other therapeutic areas, such as multiple sclerosis, pediatric growth hormone deficiency/muscular atrophy, diabetes, arthritis, wound healing, obesity, chronic pain, and cancer recovery. Medgenics, Inc. was founded in 2000 and is based in Vienna, Virginia.

Entremed Inc (NASDAQ:ENMD) - EntreMed, Inc., a clinical-stage pharmaceutical company, engages in developing therapeutics for the treatment of cancer and inflammatory diseases. It is developing primarily ENMD-2076, a selective angiogenic kinase inhibitor for the treatment of cancer. ENMD-2076 is in Phase I studies in advanced cancers, multiple myeloma, and leukemia. The companys other drug candidates include MKC-1, an oral cell-cycle inhibitor with activity against the mTOR pathway, which has completed Phase II clinical trials for cancer; ENMD-1198, an orally-active antimitotic agent that has completed a Phase I clinical trial in advanced cancers; and Panzem (2ME2), an orally active compound, which is under Phase I clinical trial for the treatment of rheumatoid arthritis. EntreMed, Inc. was founded in 1991 and is headquartered in Rockville, Maryland.

FIRSTBANK CORP/ALMA MICH (NASDAQ:FBMI) - Firstbank Corporation, through its subsidiaries, provides commercial banking products and services. It accepts checking, savings, and time deposits. The company also provides commercial, mortgage, agricultural, real estate, real estate mortgage, real estate construction, home improvement, automobile, and consumer loans. In addition, it offers trust, security brokerage, and title insurance services, as well as armored car services. The company operates 53 branch offices in central Michigan. Firstbank Corporation was founded in 1894 and is headquartered in Alma, Michigan.

APCO OIL AND GAS INTL INC (NASDAQ:APAGF) - Apco Oil and Gas International Inc. operates as an oil and gas exploration and production company with a focus on South America. The companys principal concessions include Entre Lomas, Bajada del Palo, and Charco del Palenque concessions located in the Neuquen basin, Argentina; and the Agua Amarga exploration permit situated in the Neuquen basin, Argentina. As of December 31, 2009, it has interests in nine oil and gas producing concessions and one exploration permit in Argentina, as well as two exploration and production contracts in Colombia. The company was formerly known as Apco Argentina Inc. and changed its name to Apco Oil and Gas International Inc. in July 2009. The company was founded in 1970 and is headquartered in Tulsa, Oklahoma. Apco Oil and Gas International Inc. is a subsidiary of Williams Companies, Inc.

CYTOMEDIX INC (OTC:CMXI) - Cytomedix, Inc., a biotechnology company, engages in the development, sale, and licensing of regenerative biological therapies for wound care, inflammation, and angiogenesis in the United States. The company provides the AutoloGel System, a device for the production of platelet rich plasma gel that is derived from the patients own blood. Its products include the AutoloGel System Centrifuge II, the AutoloGel wound dressing Kit, and AutoloGel reagents kit that are used for the treatment of exuding wounds, such as leg ulcers, pressure ulcers, and diabetic ulcers, as well as for the management of mechanically or surgically debrided wounds. The company also focuses on developing CT-112, which is an anti-inflammatory peptide. Cytomedix, Inc. sells its products primarily to health care providers. The company was formerly known as Autologous Wound Therapy, Inc. and changed its name to Cytomedix, Inc. in 2000. Cytomedix, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net